PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Mesna→

Mesna PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
19767-45-4
Molecular formula
C2H5NaO3S2
Molecular weight
164.18 g/mol
Drug class
Uroprotective thiol compounddetoxifying agent for oxazaphosphorine-derived urotoxic metabolites
Mechanism of action
The sulfhydryl group of mesna reacts chemically with urotoxic ifosfamide metabolites, particularly acrolein, in urine to form stable, less toxic thioether products, reducing haemorrhagic cystitis risk. It does not prevent other systemic toxicities of ifosfamide.
Indications / reported uses
  • Prevention of ifosfamide-induced haemorrhagic cystitis in patients receiving ifosfamide; the administration schedule is tied to the ifosfamide regimen and product instructions

Sources: US DailyMed — Mesna injection/tablets · NLM MeSH — Mesna · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Mesna PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Mesna Permitted Daily Exposure (PDE) report (the Mesna PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Mesna Occupational Exposure Limit (OEL) report (the Mesna OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.